Acalabrutinib

Acalabrutinib, also known by its brand name Calquence, is a medication used to treat certain blood cancers. It works by specifically targeting a protein called BTK, which helps cancer cells grow. This medication is designed to be more precise in blocking BTK compared to some earlier treatments, meaning it interferes less with other similar proteins in the body. This precision can often lead to fewer heart-related side effects. In this topic, you can learn more about how acalabrutinib works, what to expect during your treatment, and how to manage potential side effects.